Cite
HARVARD Citation
Lerner, A. et al. (2020). Is Universal Patient Access to Fulvestrant in Hormone Receptor-positive Advanced Breast Cancer Justified? A UK Retrospective Multicentre Study. Clinical oncology. 32 (8), pp. e167-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lerner, A. et al. (2020). Is Universal Patient Access to Fulvestrant in Hormone Receptor-positive Advanced Breast Cancer Justified? A UK Retrospective Multicentre Study. Clinical oncology. 32 (8), pp. e167-. [Online].